Monday, March 27, 2023
News on Pathogens and Preparedness
Global Biodefense
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe
No Result
View All Result
Global Biodefense
No Result
View All Result
Home Biodetection

DARPA Biochronicity Program Planning Grand Challenge

by Global Biodefense Staff
July 29, 2014

The Biological Technologies Office (BTO) of the Defense Advanced Research Projects Agency (DARPA) is seeking innovative ideas to support the design of a potential Grand Challenge to leverage and advance DARPA investments in multidisciplinary predictive modeling of biological networks linked to cyclic/dynamic biological signatures and processes.

The program, termed Biochoronicity, seeks to build on research which suggests it may be possible to diagnose and predict the state of human health and disease, including distinction between different clinical phenotypes and prediction of disease evolution, based primarily on bio-markers present in peripheral blood.

DARPA BTO is interested in novel concepts to enable quantitative diagnoses and prediction of human health and disease, resiliency, clinical phenotypes and disease trajectories based upon easily measured time-sampled molecular data, which may include but is not limited to RNA, DNA, protein, and metabolic  profiles.

In order to foster new and innovative ideas, DARPA is considering developing a Grand Challenge that will require the use of dynamic mathematical models that integrate multiple types of data across time to enable health and disease predictions. In such a challenge, participants would be provided with a set of clinical molecular data (e.g. genomic, proteomic and other data), and associated metadata (e.g. age of patients, physiologic measures) and asked to quantitatively predict patients’ health status and susceptibility to disease, and/or possibly provide early diagnoses of chronic disease. New modeling techniques employing the latest advances in mathematics, biology and information sciences would be encouraged.

This RFI is specifically requesting information to help design the data collection, pre-analysis, and Challenge question formulation that would take place prior to announcing a potential Grand Challenge.

DARPA is seeking compelling proof-of-principle for quantitative prediction of any or all of the following conditions: infectious diseases, chronic diseases, autoimmune diseases and/or neurodegenerative pathologies. Data collection that leverages ongoing studies or trials resulting in lower costs is encouraged.

Total duration of the data collection phase including cohort management, data collection, pre-analyses of data and formulation of Challenge questions would be no longer than 12 months in duration.

Further details are available under Solicitation Number: DARPA-SN-14-48.  The response deadline is August 14, 2014.

Tags: BiomarkersDARPARFI

Related Posts

Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA
Funding News

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
two soldiers are in head-to-toe hazmat suits with respirator masks while tending to a mannikin on a stretcher
CBRNE

Protection from Biothreats: DOD to Modernize Medical Countermeasures Development

January 10, 2023
Killing Anthrax More Quickly with Hot Air Decontamination
CBRNE

Killing Anthrax More Quickly with Hot Air Decontamination

January 4, 2023
New Material Helps Train First Responders on Biothreats
Biodetection

New Material Helps Train First Responders on Biothreats

January 4, 2023
Load More

Latest News

Biodefense Headlines – 26 March 2023

March 26, 2023
Biodefense Headlines – 12 March 2023

Biodefense Headlines – 12 March 2023

March 12, 2023
Partner Therapeutics’ Novel Approach to Stratify Sepsis Patients Gains Backing From BARDA

Biopreparedness Research Virtual Environment (BRaVE) Initiative Backed by $105M DOE Funding

January 25, 2023
Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

Influenza Proteins Tilt and Wave in ‘Breath-like’ Motions

January 25, 2023

Subscribe

  • About
  • Contact
  • Privacy
  • Subscribe

© 2022 Stemar Media Group LLC

No Result
View All Result
  • Featured
  • COVID-19
  • Funding
  • Directory
  • Jobs
  • Events
  • Subscribe

© 2022 Stemar Media Group LLC